ArticleCancers2024

High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer.

Tomonori Tanei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.